Home
Subscription
January 2025 issue
BACK ISSUES
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
|
2014 Issues
December 2014 Issue
• Feature - With Optimism!
• Appreciation
• New Drug Review: Dulaglutide (Trulicity - Lilly)
• Index for Volume 9, 2014
November 2014 Issue
• Feature - Serious Medication Errors Must be Reported – for Educational and Preventative Purposes!
• New Drug Review: Bazedoxifene acetate/conjugated estrogens (Duavee - Pfizer)
October 2014 Issue
• Feature - Health, Wellness, and Cigarettes
• New Drug Review: Apremilast (Otezla - Celgene)
September 2014 Issue
• Feature - Voters in North Dakota Should Oppose the Challenge to the Pharmacy Ownership Law!
• Chantix Should be Available Without a Prescription from a Pharmacist!
• New Drug Review: Empagliflozin (Jardiance - Boehringer-Ingelheim; Lilly)
August 2014 Issue
• Feature - Hydrocodone, Zohydro ER, Pain Relief, Addiction, and Death—What Are Our Priorities?
• New Drug Review: Albiglutide
(Tanzeum - GlaxoSmithKline)
July 2014 Issue
• Feature - Patients Held Hostage!
Exorbitant Drug Prices Will Result in Rationing of Treatment and Price Controls!
• New Drug Review: Umeclidinium bromide/vilanterol trifenatate (Anoro Ellipta - GlaxoSmithKline)
June 2014 Issue
• Feature - More than 10 Colleges of Pharmacy Will Close in the Next 20 Years! UNLESS . . . . .
• New Therapeutic Agents Marketed in the United States in 2013
May 2014 Issue
• Feature - Bigger Won't Be Better If Pfizer Acquires AstraZeneca! And Tens of Thousands Will Lose Their Jobs
• New Drug Review: Avanafil (Stendra - Auxilium; Vivus)
April 2014 Issue
• Feature - Pharmacy's National Treasure – COMMUNITY PHARMACISTS! But They are Threatened!
• New Drug Review: Dapagliflozin propanediol (Farxiga - Bristol-Myers Squibb; AstraZeneca)
March 2014 Issue
• Feature - Over-The-Counter Drug Monograph System – PAST, PRESENT AND FUTURE
• New Drug Review: Dolutegravir sodium (Tivicay - GlaxoSmithKline; ViiV)
February 2014 Issue
• Feature - Commendation for CVS!
• Commendation for the Pharmacies that Never Sold or have Discontinued the Sale of Tobacco Products!
• The Tipping Point Should Become a Domino Effect!
• Chantix Should be Available Without a Prescription from a Pharmacist!
• New Drug Review: Sofosbuvir (Sovaldi - Gilead)
January 2014 Issue
• Feature - We Will Try Resolutions Again but Pharmacy May Need a Revolution!
• New Drug Review: Vortioxetine hydrobromide (Brintellix - Lundbeck; Takeda)
| |
